Case Report Suggests Omalizumab May Help Manage Recurrent Trastuzumab Hypersensitivity
A case report suggests that biweekly omalizumab may help manage recurrent hypersensitivity reactions to trastuzumab, allowing completion of curative-intent HER2-targeted ...


